Celularity Inc SEC filings CELU

Celularity Inc has 560 filings in SEC EDGAR's recent list, going back to Nov 5, 2018. Its latest annual report, Form 10-K, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 20, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K/A Amended annual report Oct 20, 2026 Dec 31, 2025
10-K Annual report Apr 30, 2026 Dec 31, 2025
ARS Annual report to shareholders Nov 7, 2025 Dec 31, 2024
10-K/A Amended annual report May 21, 2025 Dec 31, 2024
10-K Annual report May 8, 2025 Dec 31, 2024
10-K Annual report Jul 30, 2024 Dec 31, 2023
ARS Annual report to shareholders May 1, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K/A Amended annual report Jul 15, 2022 Dec 31, 2021
10-K Annual report Mar 31, 2022 Dec 31, 2021
10-K/A Amended annual report May 24, 2021 Dec 31, 2020
10-K Annual report Mar 4, 2021 Dec 31, 2020
10-K Annual report Mar 24, 2020 Dec 31, 2019

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CELU (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Florham Park, NJ
SEC filer status
, Emerging growth company
SEC CIK
1752828
Former names
GX Acquisition Corp. (until Jul 19, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.